Dr Jitendra Singh Unveils ‘SUJVIKA’ AI-Driven Biotech Data Portal to Strengthen India’s Bioeconomy Vision

By mapping sector-wise trends and highlighting high-volume imports, the portal enables researchers, startups, and manufacturers to identify areas of import dependency and prioritise domestic innovation.

Union Minister Dr Jitendra Singh has launched ‘SUJVIKA’, an AI-Driven Biotech Data Portal positioning biotechnology and digital intelligence at the centre of India’s ambition to build a USD 1 trillion bioeconomy by 2047.

Developed in collaboration with the Association of Biotechnology Led Enterprises (ABLE), ‘SUJVIKA’ functions as a Trade Statistics Digital Intelligence Platform. It presents authenticated and structured data on biotechnology imports, including biochemical products, industrial enzymes, and other high-value biotech materials.

By mapping sector-wise trends and highlighting high-volume imports, the portal enables researchers, startups, and manufacturers to identify areas of import dependency and prioritise domestic innovation.

The announcement coincides with the 40th Foundation Day of the Department of Biotechnology, established in 1986 to strengthen India’s life sciences ecosystem. Over four decades, DBT has evolved from building laboratory capacity to fostering startups, enabling translational research, and shaping policy frameworks for industry collaboration. Today, biotechnology is increasingly linked with digital tools, supply-chain intelligence, and precision innovation.

The platform is expected to support indigenisation strategies, strengthen public-private partnerships, and guide research investments toward products that India currently sources from overseas.

For a country seeking resilience in health security and biomanufacturing, access to reliable trade intelligence could help reduce vulnerability in critical supply chains.

Dr Jitendra Singh said, “The next industrial revolution will be biotechnology-driven, and India is steadily moving towards building a USD 1 trillion bioeconomy by 2047 under the vision of Viksit Bharat.”

He added that India has ensured it does not remain a late entrant in emerging technologies and has positioned biotechnology as a key driver of future economic growth.

The Minister highlighted that biotech startups in India have increased from fewer than 100 in 2014 to over 11,000 today, while the bioeconomy has expanded from nearly USD 10 billion in 2014 to USD 165.7 billion in 2024. India now ranks among the leading global biotechnology destinations and vaccine manufacturing hubs.

Policy momentum has also accelerated under the BioE3 framework, Biotechnology for Economy, Environment and Employment, approved by the Union Cabinet.

Institutions such as the Biotechnology Industry Research Assistance Council (BIRAC) and the Biotechnology Research and Innovation Council (BRIC) are implementing initiatives to promote high-performance biomanufacturing. Infrastructure support includes six biofoundries, 21 advanced bio-enabler facilities, and 95 bio-incubators across 21 States and Union Territories, supporting over 1,800 incubatees.

Stay tuned for more such updates on Digital Health News